Sertera Biopsy Device
Payments companies reported to CMS as associated with Sertera Biopsy Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sertera Biopsy Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sertera Biopsy Device
These are the largest totals companies reported as associated with Sertera Biopsy Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stacy Smith-Foley | Little Rock, AR | Diagnostic Radiology | $350.00 |
| Meghan Mckeon | Springfield, MO | Diagnostic Radiology | $95.23 |
| Ronald Beaton | Port St Lucie, FL | Diagnostic Radiology | $92.35 |
| Fatima Soliman | New York, NY | Diagnostic Radiology | $80.17 |
| Huy Pham | Savannah, GA | Diagnostic Radiology | $70.34 |
| Deepak Das | New Port Richey, FL | Diagnostic Radiology | $68.13 |
| Sandor Szilagyi | New York, NY | Diagnostic Radiology | $65.60 |
| Aaron Andrews | Tampa, FL | Vascular & Interventional Radiology | $65.59 |
| Kurt Luhmann | Tallahassee, FL | Diagnostic Radiology | $42.25 |
| Maribel Urrutia | Charlotte, NC | Diagnostic Radiology | $42.25 |
Prescribed Sertera Biopsy Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.